Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Correlation between early 18F-FDG PET/CT response to BRAF and MEK inhibition and survival in patients with BRAF-mutant metastatic melanoma.

Schmitt RJ, Kreidler SM, Glueck DH, Amaria RN, Gonzalez R, Lewis K, Bagrosky BM, Kwak JJ, Koo PJ.

Nucl Med Commun. 2016 Feb;37(2):122-8. doi: 10.1097/MNM.0000000000000406.

PMID:
26440571
2.

Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.

Hong JW, Lee S, Kim DC, Kim KH, Song KH.

Ann Dermatol. 2014 Apr;26(2):195-202. doi: 10.5021/ad.2014.26.2.195. Epub 2014 Apr 30.

3.

Frequency of BRAF Mutation and Clinical Relevance for Primary Melanomas.

Lee HW, Song KH, Hong JW, Jeon SY, Ko DY, Kim KH, Kwon HC, Lee S, Kim SH, Kim DC.

Korean J Pathol. 2012 Jun;46(3):246-52. doi: 10.4132/KoreanJPathol.2012.46.3.246. Epub 2012 Jun 22.

4.

Driver mutations in melanoma: lessons learned from bench-to-bedside studies.

Mehnert JM, Kluger HM.

Curr Oncol Rep. 2012 Oct;14(5):449-57. doi: 10.1007/s11912-012-0249-5. Review.

5.

Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.

PiƩrard GE.

ISRN Dermatol. 2012;2012:828146. doi: 10.5402/2012/828146. Epub 2012 Jan 11.

6.

Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Greenwald HS, Friedman EB, Osman I.

Melanoma Res. 2012 Feb;22(1):1-8. doi: 10.1097/CMR.0b013e32834e6aa0. Review.

7.

Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.

Kvaskoff M, Whiteman DC, Zhao ZZ, Montgomery GW, Martin NG, Hayward NK, Duffy DL.

Twin Res Hum Genet. 2011 Oct;14(5):422-32. doi: 10.1375/twin.14.5.422.

8.

Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry.

Beadling C, Heinrich MC, Warrick A, Forbes EM, Nelson D, Justusson E, Levine J, Neff TL, Patterson J, Presnell A, McKinley A, Winter LJ, Dewey C, Harlow A, Barney O, Druker BJ, Schuff KG, Corless CL.

J Mol Diagn. 2011 Sep;13(5):504-13. doi: 10.1016/j.jmoldx.2011.04.003. Epub 2011 Jul 2. Erratum in: J Mol Diagn. 2012 Jul;14(4):418.

9.

The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

Whiteman DC, Pavan WJ, Bastian BC.

Pigment Cell Melanoma Res. 2011 Oct;24(5):879-97. doi: 10.1111/j.1755-148X.2011.00880.x. Epub 2011 Aug 16. Review.

10.

Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma.

Anna B, Blazej Z, Jacqueline G, Andrew CJ, Jeffrey R, Andrzej S.

Expert Rev Dermatol. 2007;2(4):451-469.

11.

Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.

Ng B, Zakrzewski J, Warycha M, Christos PJ, Bajorin DF, Shapiro RL, Berman RS, Pavlick AC, Polsky D, Mazumdar M, Montgomery A, Liebes L, Brooks PC, Osman I.

Clin Cancer Res. 2008 Oct 1;14(19):6253-8. doi: 10.1158/1078-0432.CCR-07-4992.

Items per page

Supplemental Content

Write to the Help Desk